NeuroSense Therapeutics Ltd. ($NRSN)
Filing Information
| Accession Number | 0001213900-26-069662 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 17, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
250,000
Total Value
$200,000.00
P&L
-11.9% ($23,750.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Ordinary Shares | โ | Jun 16, 2026 | Purchase | 250,000 | $0.80 | $200,000.00 | 1,504,050 | Direct | โ | View Details |